respiratory pathology Flashcards
Describe the pathogenesis of ARDS
● Injury to alveolar capillary membrane
● Acute inflammatory response (neutrophil mediated)
● Increased vascular permeability - leads to alveolar flooding
● fibrin deposition
● Formation of hyaline membranes
● Widespread surfactant abnormalities (damage to type II pneumocytes)
● Eventually leads to organisation with scarring
What conditions are associated with the development of ARDS?
● Infection - sepsis, diffuse pulmonary infection, gastric aspiration
● Physical/injury - trauma to head, near drowning, burns or radiation
● Inhaled irritants - O2 toxicity, smoke, irritant gases and chemicals
● Chemical injury - barbiturates, heroin, paraquat
● Haematological conditions - multiple transfusions, DIC
● Other - pancreatitis, uraemia, cardiopulmonary bypass
What is the definition of asthma?
Asthma is a chronic disorder of the conducting airways, usually caused by an immunological
reaction, which is marked by episodic bronchoconstriction due to increased airway sensitivity to
a variety of stimuli, inflammation of the bronchial walls and increased mucus secretion
Describe the pathogenesis of acute atopic asthma
● It is a classic example of IgE mediated (Type 1) hypersensitivity
● Atopic triggers include: environmental allergens e.g. dust, pollen, dander, food
● On re-exposure to the antigen, the antigen induces cross linking of IgE bound to
previously sensitised mast cells .
● These mast cells release preformed mediators that directly and indirectly via neuronal
reflexes result in bronchospasm, increased vascular permeability, mucus production and
recruitment of leukocytes
What are potential triggers for non-atopic asthma?
● Respiratory viruses, air pollutants, exercise, cold
● Can also be drug induced i.e. aspirin
● Occupational triggers - fumes from epoxy or resins, organic and chemical dusts (wood,
cotton), gases or other chemicals (formaldehyde/penicillin)
● Cigarette smoke also a trigger
Bronchiectasis
What is bronchiectasis?
A disease characterised by permanent dilation of bronchi and bronchioles caused by destruction
of the muscle and elastic tissue, resulting from or associated with chronic necrotizing infections.
Also involves scarring and persistent infections
What conditions are associated with the development of bronchiectasis?
● Congenital/hereditary conditions - cystic fibrosis, immunodeficiency, ciliary dyskinesia
● Post infectious - usually necrotising pneumonia - staph aureus, haemophilus, TB,
pseudomonas, some viral and fungal infections
● Bronchial obstruction - tumour or foreign body, mucous impaction
● Idiopathic in 25-50% of cases
What clinical conditions can cause a fat embolism?
● Anything that results in fat globules travelling within the circulation
● Most commonly long bone fractures - common in severe trauma but <10% are clinically
significant
● Can rarely occur with burns and soft tissue trauma
What is the pathogenesis of fat embolism syndrome?
● Mechanical obstruction of microvasculature in the lungs and brain by fat globules,
aggregated platelets and RBCs
● Biochemical injury from FFAs from fat globules causing endothelial injury, platelet
activation and mediator release
What are the potential clinical sequelae of fat embolism?
● Majority are asymptomatic
● Neurological - altered LOC
● Pulmonary - tachypnoea, dyspnoea, hypoxia
● Haematological - thrombocytopaenia and anaemia
Describe the pathogenesis of thrombotic pulmonary embolism
PEs originate from deep vein thrombosis (the majority from the lower limb)
Fragmented thrombi from DVTs are carried through the venous system and into the right side of
the heart before lodging in the pulmonary arterial vasculature including the main pulmonary
artery, the artery bifurcation or the smaller branching arteries
What factors determine the severity of the pathophysiological response to a pulmonary
embolism?
● Extent of pulmonary artery blood flow obstructed (Main one and the answer needed to
pass)
● Size of the vessel occluded
● Number of emboli
● Overall cardiovascular status
● Release of vasoactive factors, such as thromboxane A2
What are the symptoms and signs of a pulmonary embolism?
Most PEs are small and produce no symptoms or signs at all (estimated 60-80% are
asymptomatic)
Symptoms
● Chest pain - typically pleuritic
● Dyspnoea
● Syncope
Signs
● Hypoxia
● Tahypnpoea
● Tachycardia
● Hypotension
● Shock/sudden death
● Acute right heart failure
● Fever
● Haemoptysis
What are some risk factors for PE?
Primary factors - factor V leiden, antiphospholipid syndrome, prothrombin mutations
Secondary factors - obesity, OCP, cancer, immobilisation, long haul flights, pregnancy, central
venous line, hip fractures
What are the potential clinical sequelae of a pulmonary thrombo-embolism?
Again, this relates to the size and number of emboli and overall state of the underlying
cardiovascular status.
● Majority are asymptomatic
● Severe PEs can cause sudden death
● Large PEs can cause haemodynamic compromise and shock
● PE can lead to pulmonary infarction causing some of the signs and symptoms listed
above
● May also cause pulmonary hypertension
List other types of emboli
● Fat embolism
● Air embolism
● Amniotic fluid embolism
● Foreign body i.e. fragment of a catheter
● Tumour embolism
What is emphysema?
A chronic lung condition characterised by irreversible enlargement the airspaces distal to the
terminal bronchiole, accompanied by destruction of alveolar walls without fibrosis
Describe the pathogenesis of emphysema
● Loss of cellular homeostasis - caused by exposure to toxic substances such as tobacco
smoke and inhaled pollutants which induces ongoing inflammation, epithelial cell death
and extracellular matrix proteolysis
● Protease-antiprotease imbalance leading to destructive protease activity
● Alpha 1 antitrypsin is a major protease inhibitor and a hereditary deficiency can lead to
emphysema at a younger age
● Accumulation of neutrophils, macrophages and lymphocytes results in the release of
elastases, cytokines and oxidants that cause epithelial injury and proteolysis of the
extracellular matrix
● Elastin degradation products further increase the inflammation
● Smoke depletes antioxidant mechanisms, further adding to the damage
● The end result is destruction of the alveolar walls without fibrosis